Ilex Capital Partners’s Astera Labs ALAB Stock Holding History

Ilex Capital Partners’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,190	Closed	-$847K	–	270
2025 Q1	$847K	Buy	+14,190	New	+$1.31M	0.03%	180

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

Ilex Capital Partners's ALAB Position: Q2 2025 in Review

Ilex Capital Partners sold out of Astera Labs (ALAB) in Q2 2025, closing a stake of 14,190 shares — an estimated $847K sold.

Ilex Capital Partners first reported a position in ALAB in Q1 2025 and held it in 1 quarter. The position peaked at $847K in Q1 2025. 513 funds tracked by Wall St. Rank hold ALAB as of Q2 2025.

Ilex Capital Partners reported no remaining Astera Labs position as of Q2 2025 after selling out during the quarter.
Ilex Capital Partners sold 14,190 Astera Labs shares in Q2 2025, an estimated $847K.
Ilex Capital Partners first reported a position in Astera Labs in Q1 2025 and held it in 1 quarter.
Ilex Capital Partners's Astera Labs position peaked at $847K in Q1 2025.
513 funds tracked by Wall St. Rank held Astera Labs as of Q2 2025.

Based on Ilex Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.